Three-phase Tc-99m labeled RBC scintigraphy of a splenic hemangioma

Clinical Nuclear Medicine

Volumn 22, Issue 3, 1997, Pages 158-160

  Phillpott, Justin ^a   Ali, Seham A ^a   Briscoe, Elma G ^a   Cesani, Fernando ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Splenic Hemangiomas; Tc 99m RBCs

Indexed keywords

TECHNETIUM 99M;

ADULT; ARTICLE; CASE REPORT; CELL LABELING; ECHOGRAPHY; ERYTHROCYTE; HEMANGIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN;

ERYTHROCYTES; HEMANGIOMA; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SPLENIC NEOPLASMS; TECHNETIUM;

EID: 0030939949     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199703000-00004     Document Type: Article

References (3)

1. Ros PR, Moser RP, Dachman AH, et al: Hemangioma of the spleen: Radiologic-Pathologic correlation in ten cases. Radiology 162:73, 1987.
2. Husni EA: The clinical course of splenic hemangioma. Arch Surg 1961.
3. Front D, Israel O, Groshar D, et al: Technetium-99m-labeled red blood cell imaging. Semin Nucl Med 3:226, 1984.